ABSTRACT
We report the case of a 49-year-old woman who was admitted with community-acquired pneumonia. The medical state worsened despite administration of antibiotics. She was intubated and ventilated because of respiratory distress. Several hours after intubation, she developed massive subcutaneous emphysema. The bronchoscopy showed tracheal transmural rupture 3 cm long on the posterior wall of the trachea. The high-risk surgery and massive doses of catecholamine favoured conservative treatment with bilateral endobronchial intubation and veno-venous extracorporeal membrane oxygenation. The patient made a full recovery.
Subject(s)
Community-Acquired Infections/therapy , Extracorporeal Membrane Oxygenation/methods , Intubation, Intratracheal/methods , Pulmonary Emphysema/therapy , Respiratory Distress Syndrome/therapy , Subcutaneous Emphysema/therapy , Combined Modality Therapy/methods , Community-Acquired Infections/diagnosis , Female , Humans , Middle Aged , Pulmonary Emphysema/diagnosis , Respiratory Distress Syndrome/diagnosis , Subcutaneous Emphysema/diagnosis , Treatment OutcomeABSTRACT
AIMS: Endothelin-1 (ET-1) promotes endothelial cell growth. Endothelial cell proliferation involves the activation of Ca2+-activated K+ channels. In this study, we investigated whether Ca2+-activated K+ channels with big conductance (BK(Ca)) contribute to endothelial cell proliferation induced by ET-1. METHODS: The patch-clamp technique was used to analyse BK(Ca) activity in endothelial cells derived from human umbilical cord veins (HUVEC). Endothelial proliferation was examined using cell counts and measuring [3H]-thymidine incorporation. Changes of intracellular Ca2+ levels were examined using fura-2 fluorescence imaging. RESULTS: Characteristic BK(Ca) were identified in cultured HUVEC. Continuous perfusion of HUVEC with 10 nmol L(-1) ET-1 caused a significant increase of BK(Ca) open-state probability (n = 14; P < 0.05; cell-attached patches). The ET(B)-receptor antagonist (BQ-788, 1 micromol L(-1)) blocked this effect. Stimulation with Et-1 (10 nmol L(-1)) significantly increased cell growth by 69% (n = 12; P < 0.05). In contrast, the combination of ET-1 (10 nmol L(-1)) and the highly specific BK(Ca) blocker iberiotoxin (IBX; 100 nmol L(-1)) did not cause a significant increase in endothelial cell growth. Ca2+ dependency of ET-1-induced proliferation was tested using the intracellular Ca2+-chelator BAPTA (10 micromol L(-1)). BAPTA abolished ET-1 induced proliferation (n = 12; P < 0.01). In addition, ET-1-induced HUVEC growth was significantly reduced, if cells were kept in a Ca2+-reduced solution (0.3 mmol L(-1)), or by the application of 2 aminoethoxdiphenyl borate (100 micromol L(-1)) which blocks hyperpolarization-induced Ca2+ entry (n = 12; P < 0.05). CONCLUSION: Activation of BK(Ca) by ET-1 requires ET(B)-receptor activation and induces a capacitative Ca2+ influx which plays an important role in ET-1-mediated endothelial cell proliferation.
Subject(s)
Egtazic Acid/analogs & derivatives , Endothelial Cells/physiology , Endothelin-1/physiology , Potassium Channels, Calcium-Activated/physiology , Calcium/metabolism , Calcium/physiology , Cell Count , Cell Division/drug effects , Cell Division/physiology , Cells, Cultured , Chelating Agents/pharmacology , Culture Media , Dose-Response Relationship, Drug , Egtazic Acid/pharmacology , Electric Conductivity , Endothelial Cells/drug effects , Endothelin B Receptor Antagonists , Humans , Membrane Potentials/physiology , Oligopeptides , Peptides/pharmacology , Piperidines , Potassium Channels, Calcium-Activated/antagonists & inhibitorsABSTRACT
Recently, we demonstrated a strong upregulation of activin expression after skin injury. Furthermore, overexpression of this transforming growth factor beta family member in the skin of transgenic mice caused dermal fibrosis, epidermal hyperthickening and enhanced wound repair. However, the role of endogenous activin in wound healing has not been determined. To address this question we overexpressed the soluble activin antagonist follistatin in the epidermis of transgenic mice. These animals were born with open eyes, and the adult mice had larger ears, longer tails and reduced body weight compared with non-transgenic littermates. Their skin was characterized by a mild dermal and epidermal atrophy. After injury, a severe delay in wound healing was observed. In particular, granulation tissue formation was significantly reduced, leading to a major reduction in wound breaking strength. The wounds, however, finally healed, and the resulting scar area was smaller than in control animals. These results implicate an important function of endogenous activin in the control of wound repair and scar formation.
Subject(s)
Activins/antagonists & inhibitors , Activins/biosynthesis , Growth Substances/biosynthesis , Skin/injuries , Wound Healing/physiology , Activins/genetics , Animals , Bone Morphogenetic Proteins/biosynthesis , Cell Differentiation , Cell Division , Cloning, Molecular , Ear/abnormalities , Epidermis , Follistatin , Gene Expression Regulation , Growth Substances/genetics , Keratinocytes/cytology , Mice , Mice, Transgenic , Skin Abnormalities , Skin Physiological Phenomena , TransgenesABSTRACT
A recent study from our laboratory demonstrated a strong upregulation of activin expression during cutaneous wound healing. To further analyze the role of activin A in skin morphogenesis and wound repair, we generated transgenic mice that overexpress activin A under the control of the keratin 14 promoter. The latter targets expression of transgenes to the basal, proliferating layer of the epidermis. Hetero- as well as homozygous transgenic animals were viable and fertile. However, they were smaller than non-transgenic littermates and they had smaller ears and shorter tails. Histological analysis of their skin revealed dermal hyperthickening, mainly due to the replacement of fatty tissue by connective tissue, and an increase in suprabasal, partially differentiated epidermal layers. After cutaneous injury, a strong enhancement of granulation tissue formation was observed. Furthermore, the extent of re-epithelialization was increased in some of the wounds. These data demonstrate that activin A is a potent stimulator of the wound healing process. Using an in vivo model of local brain injury, we found that activin A also plays a significant role in the early cellular response to neuronal damage. Expression of activin mRNA and protein is markedly upregulated within a few hours of injury. If applied exogenously, recombinant activin A is capable of rescuing neurons from acute cell death. Studying the interaction between bFGF, a well-established neuroprotective agent, which is currently being tested in stroke patients, and activin A, we arrived at the unexpected conclusion that it is the strong induction of activin A by bFGF which endows the latter with its beneficial actions in patients. These findings suggest that the development of substances directly targeting activin expression or receptor binding should offer new possibilities in the acute treatment of stroke and brain trauma.
Subject(s)
Activins/physiology , Brain/physiology , Skin/drug effects , Wound Healing/drug effects , Activins/metabolism , Animals , Brain/drug effects , Brain/pathology , Brain Diseases/metabolism , Brain Diseases/pathology , Brain Injuries/metabolism , Brain Injuries/physiopathology , Humans , Skin/injuries , Skin/pathologyABSTRACT
Exogenous application of neurotrophic growth factors has emerged as a new and particularly promising approach not only to promote functional recovery after acute brain injury but also to protect neurons against the immediate effect of the injury. Among the various growth factors and cytokines studied so far, the neuroprotective and neurotrophic profile of basic fibroblast growth factor (bFGF) is the best documented. Using an animal model of acute excitotoxic brain injury, we report here that the neuroprotective action of bFGF, which is now being tested in stroke patients, depends on the induction of activin A, a member of the transforming growth factor-beta superfamily. Our evidence for this previously unknown mechanism of action of bFGF is that bFGF strongly enhanced lesion-associated induction of activin A; in the presence of the activin-neutralizing protein follistatin, bFGF was no longer capable of rescuing neurons from excitotoxic death; and recombinant activin A exerted a neuroprotective effect by itself. Our data indicate that the development of substances influencing activin expression or receptor binding should offer new ways to fight neuronal loss in ischemic and traumatic brain injury.
Subject(s)
Fibroblast Growth Factor 2/therapeutic use , Growth Substances/biosynthesis , Inhibins/biosynthesis , Kainic Acid/toxicity , Neuroprotective Agents/therapeutic use , Activins , Animals , Brain/drug effects , Growth Substances/pharmacology , Hippocampus/drug effects , Inhibins/pharmacology , Male , Mice , Mice, Inbred C57BL , Neurons/metabolismABSTRACT
Hepatocyte growth-factor (HGF) is a potent, widely produced, pleiotropic mediator of mesenchymal-epithelial interaction. In a study of changes in gene expression initiated by HGF in Balb/MK keratinocytes, we observed the induction of Neu-differentiation factor (NDF) mRNA (also known as heregulin, or HRG). Further characterization of the regulation of NDF expression in Balb/MK keratinocytes revealed potent induction by keratinocyte growth factor (KGF) and epidermal growth factor (EGF), but not by HGF/NK2, an alternative HGF isoform with motogenic but not mitogenic or morphogenic activities. Sustained treatment (8 h) of Balb/MK cells with KGF stimulated secretion of mature NDF protein into the culture medium, and Balb/ MK cells treated with purified recombinant NDF protein showed increased DNA synthesis. We also found evidence of NDF induction in two models of tissue repair in mice: in full-thickness skin wounds, following locally increased KGF production, and in kidney after partial hepatectomy, following elevation of circulating HGF levels. These results reveal that mesenchymally-derived HGF and KGF can activate autocrine NDF signaling in their epithelial targets, and suggest that this mechanism contributes to the coordination of stages of wound repair, and possibly development, where these growth factors act in concert to direct epithelial proliferation, morphogenesis and differentiation.
Subject(s)
Fibroblast Growth Factors , Growth Substances/physiology , Hepatocyte Growth Factor/physiology , Neuregulin-1/biosynthesis , Amino Acid Sequence , Animals , Cell Line , Fibroblast Growth Factor 10 , Fibroblast Growth Factor 7 , Keratinocytes/metabolism , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Skin/metabolism , Skin/pathology , Wound Healing/physiologyABSTRACT
Transforming growth factor beta (TGF-beta) is a multifunctional cytokine which plays an important role in cutaneous wound repair. To gain insight into the mechanisms of action of this growth and differentiation factor in the skin, we searched for genes which are regulated by TGF-beta1 in cultured HaCaT keratinocytes. Using the differential display RT-PCR technology we identified a gene which was strongly downregulated by TGF-beta1. The identified cDNA includes sequences of the keratin 15 (K15) gene which encodes a component of the cytoskeleton of basal cells in stratified epithelia. Surprisingly, our cDNA also included an unknown sequence. Since this cDNA lacks an open reading frame, the corresponding mRNA is likely to be nonfunctional. However, we also demonstrate a strong negative regulation of the expression of the published, functional K15 variant. Expression of K15 was also suppressed by tumor necrosis factor alpha (TNF-alpha) and to a lesser extent by epidermal growth factor (EGF) and keratinocyte growth factor (KGF). By contrast, the major basal type I keratin, K14, was upregulated by TGF-beta1, whereas TNF-alpha, EGF, and KGF had no effect. Consistent with the in vitro data, we found a significant reduction of the K15 mRNA levels after skin injury, whereas K14 expression increased during the wound healing process. Immunostaining revealed the presence of K15 in all basal cells of the epidermis adjacent to the wound, but not in the hyperproliferative epithelium above the granulation tissue. These data demonstrate that K15 is excluded from the activated keratinocytes of the hyperthickened wound epidermis, possibly as a result of increased growth factor expression in injured skin.
Subject(s)
Gene Expression Regulation , Keratins/genetics , Skin/metabolism , Transforming Growth Factor beta/pharmacology , Wound Healing , Animals , Cell Line , Down-Regulation/drug effects , Fluorescent Antibody Technique, Indirect , Gene Expression Regulation/drug effects , Humans , Keratin-14 , Keratin-15 , Keratinocytes/cytology , Keratinocytes/drug effects , Keratinocytes/metabolism , Keratins/biosynthesis , Mice , Mice, Inbred BALB C , RNA, Messenger , Reverse Transcriptase Polymerase Chain Reaction , Skin/injuries , Transforming Growth Factor beta/metabolismABSTRACT
Reepithelialization and granulation tissue formation during cutaneous wound repair are mediated by a wide variety of growth and differentiation factors. Recent studies from our laboratory provided evidence for an important role of keratinocyte growth factor (KGF) in the repair of the injured epithelium and for a novel function of the transforming growth factor-beta superfamily member activin in granulation tissue formation. KGF is weakly expressed in human skin, but is strongly upregulated in dermal fibroblasts after skin injury. Its binding to a transmembrane receptor on keratinocytes induces proliferation and migration of these cells. Furthermore, KGF has been shown to protect epithelial cells from the toxic effects of reactive oxygen species. We have identified a series of KGF-regulated genes that are likely to play a role in these processes. In addition to KGF, activin seems to be a novel player in wound healing. Activin expression is hardly detectable in nonwounded skin, but this factor is highly expressed in redifferentiating keratinocytes of the hyperproliferative wound epithelium as well as in cells of the granulation tissue. To gain insight into the role of activin in wound repair, we generated transgenic mice that overexpress activin in basal keratinocytes of the epidermis. These mice were characterized by a hyperthickened epidermis and by dermal fibrosis. Most importantly, overexpression of activin strongly enhanced the process of granulation tissue formation, demonstrating a novel and important role of activin in cutaneous wound repair.
Subject(s)
Fibroblast Growth Factors , Growth Substances/genetics , Growth Substances/metabolism , Inhibins/genetics , Inhibins/metabolism , Skin Physiological Phenomena , Wound Healing/physiology , Activins , Animals , Fibroblast Growth Factor 10 , Fibroblast Growth Factor 7 , Gene Expression/physiology , Humans , Skin/cytology , Skin/injuriesABSTRACT
Recently we demonstrated a strong induction of activin expression after skin injury, suggesting a function of this transforming growth factor-beta family member in wound repair. To test this possibility, we generated transgenic mice that overexpress the activin betaA chain in the epidermis under the control of a keratin 14 promoter. The transgenic mice were significantly smaller than control littermates, and they had smaller ears and shorter tails. In their skin, the fatty tissue was replaced by connective tissue and a severe thickening of the epidermis was found. The spinous cell layer was significantly increased, and the epidermal architecture was highly disorganized. These histological abnormalities seem to result from increased proliferation of the basal keratinocytes and abnormalities in the program of keratinocyte differentiation. After skin injury, a significant enhancement of granulation tissue formation was detected in the activin-overexpressing mice, possibly as a result of premature induction of fibronectin and tenascin-C expression. These data reveal novel activities of activin in the regulation of keratinocyte proliferation and differentiation as well as in dermal fibrosis and cutaneous wound repair.
Subject(s)
Epidermis/metabolism , Inhibins/metabolism , Skin/metabolism , Wound Healing , Activins , Animals , Cell Differentiation , Cell Division , Cloning, Molecular , Epidermis/pathology , Fibronectins/genetics , Fibronectins/metabolism , Keratinocytes/cytology , Keratinocytes/metabolism , Membrane Glycoproteins/metabolism , Mice , Mice, Transgenic , Morphogenesis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Skin/pathology , Tenascin/metabolismABSTRACT
To gain insight into the molecular mechanisms underlying the wound repair process, we searched for genes that are regulated by skin injury. Using the differential display reverse transcription-polymerase chain reaction technique, we identified a gene that was strongly induced as early as 12 h after wounding. Sequence analysis revealed the identity of the corresponding protein with skeletal muscle nascent polypeptide-associated complex (skNAC), a recently identified muscle-specific transcription factor. By in situ hybridization and immunohistochemistry, we demonstrated the specific expression of skNAC in skeletal muscle cells of the panniculus carnosus at the wound edge. Furthermore, in vitro studies with cultured myoblasts revealed expression of skNAC in differentiating and differentiated, but not in proliferating, nondifferentiated cells. Differentiation of cultured myoblasts was accompanied by simultaneous expression of skNAC and the muscle-specific transcription factor myogenin. Our results provide the first evidence for a role of skNAC in muscle repair processes. Furthermore, they demonstrate the usefulness of our approach in identifying new players in wound repair.
Subject(s)
Muscle Proteins/physiology , Muscles/metabolism , Skin/injuries , Wound Healing , Animals , Base Sequence , Cell Differentiation/genetics , Cell Line , Cloning, Molecular , DNA Primers , Female , Fluorescent Antibody Technique , Mice , Mice, Inbred BALB C , Muscle Proteins/genetics , Muscles/cytology , Rats , Up-RegulationABSTRACT
Injury to the skin initiates a series of events including inflammation, new tissue formation, and matrix remodeling. During the early inflammatory phase, polymorphonuclear leukocytes and macrophages infiltrate the wounded tissue. Once activated, they produce large amounts of reactive oxygen species (ROS) as part of their defense mechanism. Although this process is beneficial, increased levels of ROS can inhibit cell migration and proliferation and can even cause severe tissue damage. Therefore, cells must develop strategies for the detoxification of these molecules. To gain insight into the mechanisms which underlie this process, we analyzed the temporal and spatial expression pattern of various ROS-scavenging enzymes during the healing process of full-thickness excisional wounds in mice. Here we demonstrate a strong mRNA expression of two types of superoxide dismutase (SOD), as well as of catalase, and the selenoenzymes glutathione peroxidase (SeGPx) and phospholipid hydroperoxide glutathione peroxidase in normal and wounded skin. Most importantly, mRNA levels of the SODs and of SeGPx increased strongly after skin injury. In situ hybridization and immunofluorescence studies revealed the presence of these transcripts at multiple places in the wound, whereby particularly high expression levels were detected in the hyperproliferative epithelium and the hair follicles at the wound edge. These data suggest an important role of ROS-scavenging enzymes in the detoxification of ROS during cutaneous wound repair.
Subject(s)
Oxidoreductases/biosynthesis , Reactive Oxygen Species/metabolism , Wound Healing/physiology , Animals , Catalase/biosynthesis , Catalase/genetics , Gene Expression , Glutathione Peroxidase/biosynthesis , Glutathione Peroxidase/genetics , Mice , Mice, Inbred BALB C , Oxidoreductases/genetics , Phospholipid Hydroperoxide Glutathione Peroxidase , Skin/enzymology , Skin/injuries , Superoxide Dismutase/biosynthesis , Superoxide Dismutase/geneticsABSTRACT
Basic fibroblast growth factor (bFGF) exerts angiogenic and mitogenic properties in human tissue. Since changes in ion currents modulate essential Ca2+-dependent intracellular pathways in endothelial cells, we have investigated a possible contribution of Ca2+-activated K+ channels (BKCa) on bFGF-induced endothelial cell proliferation. The patch-clamp technique was used to identify BKCa and to study their modulation by bFGF in cultured endothelial cells of human umbilical cord veins (HUVEC). Cell counts of HUVEC were carried out on different days to analyze bFGF-induced cell proliferation and its influence by the specific BKCa blocker iberiotoxin (IBX). Using single-channel recordings, we found characteristic BKCa with a single-channel slope conductance of 170.3 +/- 2.1 pS (n = 7), half-maximal activation at internal pCa = 5.7 (n = 5; test potential: 80 mV), and dose-dependent block by IBX (25-100 nmol/l). In cell-attached patches bFGF (50 ng/ml) caused a significant increase in the open-state probability (NPo) after 6 min at test potentials of 80 and 100 mV (n = 28; p < 0.001), respectively, which lasted up to 30 min. After preincubation with pertussis toxin (100 ng/ml; 4 h) bFGF superfusion did not cause a significant increase in BKCa activity until 25 min had passed (n = 20; p < 0.01). Addition of 100 nmol/l IBX to the pipette solution caused a total block of BKCa within 2 min in cell-attached patches, whereas bFGF (50 ng/ml) was not able to activate BKCa. When incubated with IBX (25-100 nmol/l) every 2 days, bFGF-induced proliferation of HUVEC was significantly decreased by 50 (-41%) and 100 nmol/l (-50%) IBX (n = 5; p < 0.001) after 7 days. We conclude that activation of BKCa by bFGF may play an important role in bFGF-induced proliferation of human endothelial cells and thus might be important in the process of angiogenesis and vascular remodelling.
Subject(s)
Calcium/metabolism , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Fibroblast Growth Factor 2/pharmacology , Potassium Channel Blockers , Potassium Channels/metabolism , Cell Division/drug effects , Cells, Cultured , Endothelium, Vascular/cytology , Fibroblast Growth Factor 2/physiology , Humans , Models, Cardiovascular , Neovascularization, Pathologic , Neovascularization, Physiologic , Patch-Clamp Techniques , Peptides/pharmacologyABSTRACT
Keratinocyte growth factor (KGF) is a potent mitogen for keratinocytes which is strongly expressed at the wound edge after skin injury. Inhibition of KGF receptor signalling in the epidermis of transgenic mice caused a delay in wound reepithelialization. To determine the mechanisms of KGF action in keratinocytes, we searched for genes which are regulated by KGF. One of these genes codes for activin which we identified as a novel important player in the repair process. Furthermore, expression of a novel peroxidase was induced by KGF. The expression pattern of this enzyme during wound repair suggests that it could protect keratinocytes from reactive oxygen species during the early inflammatory phase. Taken together, our studies provide new insights into the mechanisms of action of growth factors during the healing process.
Subject(s)
Fibroblast Growth Factors , Growth Substances/genetics , Receptors, Fibroblast Growth Factor , Wound Healing/genetics , Animals , Fibroblast Growth Factor 10 , Fibroblast Growth Factor 7 , Gene Expression/physiology , Growth Substances/physiology , Humans , Mice , Mice, Transgenic , Reactive Oxygen Species/metabolism , Receptor, Fibroblast Growth Factor, Type 2 , Receptors, Growth Factor/genetics , Receptors, Growth Factor/physiology , Wound Healing/physiologyABSTRACT
We have previously identified and cloned a novel keratinocyte growth factor (KGF)-regulated gene in human keratinocytes that encodes the human homologue of a bovine non-selenium glutathione peroxidase (GPx). To gain insight into the regulation of this gene in vivo, we isolated the murine homologue from a mouse skin cDNA library. In vitro transcription/translation demonstrated that the cDNA encodes a 27 kDa protein. Furthermore, we amplified by PCR a partial cDNA that most likely corresponds to a related gene. RNase protection analysis revealed tissue-specific expression of both genes and the occurrence of alternative splicing or RNA editing of at least one of the primary transcripts. Similar to that of KGF, expression of GPx was strongly induced after cutaneous injury, and each isoform displayed unique kinetics of expression during the repair process. In situ hybridization studies demonstrated high levels of GPx mRNA in keratinocytes of the hyperproliferative epithelium at the wound edge. Since these cells express functional KGF receptors, induction of GPx expression by KGF might also occur in vivo. These data suggest a role for GPx in the protection of epithelial cells against oxidative stress, particularly during the inflammatory phase of wound repair.
Subject(s)
Glutathione Peroxidase/biosynthesis , Glutathione Peroxidase/genetics , Wound Healing/genetics , Amino Acid Sequence , Animals , Base Sequence , Cattle , Cell Division/genetics , Cloning, Molecular , Epithelial Cells , Epithelium/enzymology , Female , Gene Expression Regulation/physiology , Glutathione Peroxidase/physiology , Humans , Keratinocytes/enzymology , Mice , Mice, Inbred BALB C , Molecular Sequence Data , Molecular Weight , Multigene Family , Organ Specificity/geneticsABSTRACT
Transforming growth factor beta1 (TGF-beta1) is an important modulator of skin morphogenesis and cutaneous wound repair. To gain insight into the mechanisms of TGF-beta1 action in the skin, we used the differential display RT-PCR technique to identify genes that are regulated by this factor in cultured human keratinocytes. We obtained several partial cDNA clones. One of them was identical to the 3'-end of p11, the small and regulatory subunit of the calpactin I complex [(annexin II)2(p11)2]. RNase protection and northern blot analysis revealed specific regulation of expression of both subunits of this heterotetrameric protein (p11 and annexin II) by TGF-beta1 as well as by other growth factors, although the time course and degree of induction or suppression were different for each gene. Furthermore, we analyzed p11 and annexin II expression in normal and wounded skin. Both p11 and annexin II mRNAs were found in the dermal and epidermal compartments of normal human skin. Immunohistochemical studies demonstrated the presence of p11 at equally high levels in all layers of normal epidermis and in the hyper-proliferative epithelium at the wound edge. By contrast, annexin II expression was high in the basal layer of normal epidermis but low in the suprabasal layers and in the hyper-proliferative epithelium at the wound edge, suggesting a differentiation-specific regulation of this calpactin I subunit. The differential expression and regulation of p11 and annexin II subunits in keratinocytes suggest the existence of different ratios of monomeric versus p11-complexed annexin II that might be associated with different cellular functions.
Subject(s)
Annexin A2/genetics , Annexins/chemistry , Peptides/genetics , S100 Proteins , Wound Healing/genetics , Animals , Cells, Cultured , Gene Expression/drug effects , Humans , Immunohistochemistry , Keratinocytes/cytology , Mice , Mice, Inbred BALB C , Skin/chemistry , Skin/injuries , Transforming Growth Factor beta/pharmacologyABSTRACT
Keratinocyte growth factor is a potent and specific mitogen for different types of epithelial cells, including keratinocytes of the skin. Furthermore, it has been implicated in morphogenetic processes of several organs. To further define the mechanisms of KGF action in the skin, we attempted to identify genes which are regulated by KGF in keratinocytes. Using the differential display RT-PCR technology, a gene was identified which was strongly induced in these cells by treatment with KGF but not with serum growth factors or pro-inflammatory cytokines. Molecular cloning of the full-length cDNA revealed a strong homology of the corresponding gene product with a bovine non-selenium glutathione peroxidase. Upon transfection of COS cells with the full-length cDNA, a 27 kD cytoplasmic protein was obtained which had the expected size of glutathione peroxidase. Expression of the novel gene was detected in normal human skin and at particularly high levels in psoriatic skin, indicating a possible in vivo function of the protein in this tissue. Identification of a peroxidase as a KGF-regulated gene suggests that prevention from oxygen toxicity is a novel and specific mechanism of KGF action.
Subject(s)
Cytokines/physiology , Fibroblast Growth Factors , Glutathione Peroxidase/genetics , Growth Substances/physiology , Keratinocytes/physiology , Amino Acid Sequence , Cytoplasm/enzymology , DNA, Complementary/genetics , Fibroblast Growth Factor 10 , Fibroblast Growth Factor 7 , Gene Expression Regulation, Developmental , Humans , Molecular Sequence Data , Oxidation-Reduction , Psoriasis/genetics , Sequence Alignment , Sequence Homology, Amino Acid , Skin/enzymologyABSTRACT
We studied the temporal and spatial mRNA expression pattern of activin/inhibin beta A, beta B and alpha subunits after unilateral kainic acid lesions of the hippocampal CA3 region. We found a strikingly increased expression of beta A mRNA in the ipsilateral hippocampus 6-24 h after injury. By contrast, the beta B and alpha mRNAs were expressed at equally low levels in normal and injured hippocampi, suggesting that the beta A transcripts give rise to activin A, but not to activin AB or inhibin. In situ hybridization demonstrated the presence of beta A mRNA in neurones near the site of lesion. Expression of all known types of activin receptors could be demonstrated in normal and injured hippocampi by RT-PCR. These findings suggest a role of activin in brain injury.